Bleakley Financial Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Bleakley Financial Group's WST Position: Q3 2026 in Review
Bleakley Financial Group increased its West Pharmaceutical (WST) stake by 24% in Q3 2026, buying an estimated $847K and bringing the position to 12,572 shares worth $4.66M. The position accounts for 0.05% of the portfolio, ranked #304.
Bleakley Financial Group first reported a position in WST in Q4 2022 and has held it in 11 quarters since. 752 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Bleakley Financial Group held 12,572 shares of West Pharmaceutical worth $4.66M as of Q3 2026.
- Bleakley Financial Group bought 2,399 West Pharmaceutical shares in Q3 2026, an estimated $847K.
- West Pharmaceutical made up 0.05% of Bleakley Financial Group's portfolio in Q3 2026, its #304 holding.
- Bleakley Financial Group first reported a position in West Pharmaceutical in Q4 2022 and has held it in 11 quarters since.
- 752 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Bleakley Financial Group's 13F filing for Q3 2026, filed 13 Nov 2026.